Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218010 · ClinicalTrials.gov registry record
Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 25
- Enrollment target
NCT00218010 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 25 participants.
The verdict
NCT00218010 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Methadone is a drug that offers significant therapeutic benefits to opiate dependent women who are pregnant. Currently, it is the treatment of choice for this group of people. The purpose of this study is to determine the amount of methadone in the breast milk of women who are breastfeeding and taking methadone for opiate addiction. In addition, this study will evaluate the effects of methadone on infant neurobehavior.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2000-11 |
| Est. Completion | 2005-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218010
The ClinicalTrials.gov registry entry for NCT00218010 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00218010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218010 about?
NCT00218010 is a clinical study titled "Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2". Methadone is a drug that offers significant therapeutic benefits to opiate dependent women who are pregnant. Currently, it is the treatment of choice for this group of people. The purpose of this study is to determine the amount of methadone in the breast milk of women who are breastfeeding and taki...
What is the current status of trial NCT00218010?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2000-11. Estimated completion is 2005-09.
Who is sponsoring clinical trial NCT00218010?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.